The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.
The Framingham Heart Study is a project of Boston University & the National Heart, Lung, & Blood Institute.

Policies and Procedures

The Framingham Heart Study welcomes the interest and proposals of outside investigators. Collaboration is encouraged as it helps to maximize the scientific value of the wealth of epidemiologic data made possible by the participation of more than 15,000 individuals who enrolled in the Framingham Heart Study over the past decades. The core research of the Framingham Heart Study has focused on many aspects of cardiovascular and cerebrovascular disease. Access to the data for a wide range of investigations has enabled research discoveries related to other diseases such as stroke, osteoporosis, arthritis, obesity, eye and hearing disorders, and cancer.

After an Ancillary Study’s Principal Investigator has received approval from the FHS Executive Committee (projects seeking sponsor funding) or FHS Research Committee (non-sponsored projects), they and their research teams are expected to follow the policies below when working with FHS staff, participants, and/or participant data and materials:

  • Code of Conduct
  • Data Sharing Principles
  • Distribution for Living Tissue/Cell Resources
  • Distribution for Non-renewable Genetic Resources
  • Framingham Risk Score Policy
  • Genomic Data Sharing Policy
  • Image Files with Embedded PHI Policy
  • Initiation of an FHS Ancillary Study Involving Participant Burden
  • Principles of Endpoint Review
  • Publication Policy
  • Use of Precious DNA
  • Wi-Cell Policy